These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical data marshalled to treat HIV. Clarke T Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390 [No Abstract] [Full Text] [Related]
3. The K65R mutation: selection, frequency, and possible consequences. Moyle GJ AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671 [No Abstract] [Full Text] [Related]
4. Slow accumulation of HIV resistance mutations: implications for resource-limited settings? Stevens WS J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045 [No Abstract] [Full Text] [Related]
5. HIV drug resistance and you. Resistance overview. A look at the basics. Munk B Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502 [No Abstract] [Full Text] [Related]
6. The benefits of HIV resistance testing in optimizing drug discovery. Heilek-Snyder G; Bean P Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169 [No Abstract] [Full Text] [Related]
7. Universal access to HIV/AIDS treatment: challenges ahead. Satyanarayana K; Srivastava S Indian J Med Res; 2009 Dec; 130(6):671-4. PubMed ID: 20090125 [No Abstract] [Full Text] [Related]
8. HIV/AIDS in China. A new treatment campaign, but with limited weapons. Cohen J Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778 [No Abstract] [Full Text] [Related]
9. HIV drug resistance testing: an update for the clinician. Rice HL; Zolopa AR AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921 [No Abstract] [Full Text] [Related]
10. [Resistance investigations during HIV-therapy is necessary]. Schattenfroh S Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940 [No Abstract] [Full Text] [Related]
11. Detection and significance of minority quasispecies of drug-resistant HIV-1. Metzner KJ J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210 [No Abstract] [Full Text] [Related]
12. Why HIV drug resistance matters: an overview. Learned J Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604 [No Abstract] [Full Text] [Related]
13. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA. Hicks CB AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369 [No Abstract] [Full Text] [Related]
14. New insights into HIV resistance testing: nursing guidelines and implications. Kirton CA; Kurtyka D; Sterken DJ J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302 [TBL] [Abstract][Full Text] [Related]
15. Resisting resistance. A long road of unintentional missteps pays off. Sharp M Posit Aware; 2007; 18(2):24-5. PubMed ID: 17390486 [No Abstract] [Full Text] [Related]
16. Antiretroviral rounds. Resistance: how do you know if you don't know? Campbell TB; Katzenstein D AIDS Clin Care; 2005 Mar; 17(3):26-7. PubMed ID: 15828117 [No Abstract] [Full Text] [Related]
17. Accrued HIV evidence turns treatment dogma on its head. Check E Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150 [No Abstract] [Full Text] [Related]
18. HIV drug resistance testing: data be damned. Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172 [No Abstract] [Full Text] [Related]
19. Antiretroviral resistance in the developing world. Pillay D J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091 [No Abstract] [Full Text] [Related]
20. Accommodating uncertainty in a tree set for function estimation. Healy BC; DeGruttola VG; Hu C Stat Appl Genet Mol Biol; 2008; 7(1):Article5. PubMed ID: 18312210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]